Published by
The Street
The Street
By GlobeNewswire SUWON, Republic of Korea., Jan. 03, 2022 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will hold one-on-one meetings at BIO Partnering at JPM from January 10-14, 2022. The Company’s management will also participate in Biotech Showcase 2022, being held virtually from January 10-12, 2022 and January 17-19, 2022. Dong Ki Lee, Ph.D., Founder and Chief Executive Officer, Sun Woo Hong, Ph.D., Head of Research and Development, and June Park, Principal Scientist, will be availabl…